SXI Life Sciences
7.554,07
PKT
+3,66
PKT
+0,05
%
Werbung
Analysen zu SXI Life Sciences-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 02.05.14 | Novartis buy | Jefferies & Company Inc. | |
| 30.04.14 | Novartis overweight | JP Morgan Chase & Co. | |
| 29.04.14 | Novartis Underweight | Morgan Stanley | |
| 29.04.14 | Novartis buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 28.04.14 | Roche overweight | JP Morgan Chase & Co. | |
| 28.04.14 | Roche overweight | JP Morgan Chase & Co. | |
| 25.04.14 | Novartis Hold | Deutsche Bank AG | |
| 24.04.14 | Novartis Halten | Independent Research GmbH | |
| 24.04.14 | Novartis buy | UBS AG | |
| 23.04.14 | Novartis buy | Société Générale Group S.A. (SG) | |
| 23.04.14 | Novartis buy | S&P Capital IQ | |
| 23.04.14 | BB Biotech buy | Close Brothers Seydler Research AG | |
| 23.04.14 | Novartis Underweight | Barclays Capital | |
| 23.04.14 | Novartis buy | UBS AG | |
| 23.04.14 | Novartis Hold | Deutsche Bank AG | |
| 22.04.14 | Novartis Neutral | JP Morgan Chase & Co. | |
| 22.04.14 | BB Biotech buy | equinet AG | |
| 17.04.14 | Novartis Neutral | JP Morgan Chase & Co. | |
| 17.04.14 | BB Biotech kaufen | Independent Research GmbH | |
| 17.04.14 | Novartis buy | UBS AG | |
| 16.04.14 | Roche buy | Citigroup Corp. | |
| 16.04.14 | Roche overweight | JP Morgan Chase & Co. | |
| 16.04.14 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 16.04.14 | Roche overweight | Morgan Stanley | |
| 16.04.14 | Roche buy | UBS AG | |
| 16.04.14 | Roche overweight | Barclays Capital | |
| 15.04.14 | Roche kaufen | Independent Research GmbH | |
| 14.04.14 | Roche buy | Jefferies & Company Inc. | |
| 14.04.14 | Novartis Hold | Jefferies & Company Inc. | |
| 11.04.14 | Roche buy | UBS AG | |
| 10.04.14 | Roche overweight | JP Morgan Chase & Co. | |
| 10.04.14 | Novartis Neutral | JP Morgan Chase & Co. | |
| 08.04.14 | Roche Conviction Buy | Goldman Sachs Group Inc. | |
| 08.04.14 | Roche overweight | JP Morgan Chase & Co. | |
| 08.04.14 | Novartis buy | UBS AG | |
| 08.04.14 | Roche buy | UBS AG | |
| 02.04.14 | Roche buy | Deutsche Bank AG | |
| 02.04.14 | Novartis Hold | Deutsche Bank AG | |
| 01.04.14 | Novartis Neutral | JP Morgan Chase & Co. | |
| 01.04.14 | Roche overweight | JP Morgan Chase & Co. |